Unaudited Results for the quarter and half year ended 30.09.2025
TRANSPEK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transpek Industry's board approved standalone and consolidated unaudited results for Q2 and H1 FY26 on November 13, 2025. Profit before tax for H1 FY26 stood at ₹3,789.76 lakhs, up about 61% from ₹2,355.83 lakhs in H1 FY25, showing strong operating performance. Net cash from operations remained healthy at ₹4,891 lakhs, though lower than ₹6,902.63 lakhs a year ago. The balance sheet remains strong with total equity at ₹76,795 lakhs against total borrowings of just ₹2,526 lakhs, and the auditor (Bansi S. Mehta & Co.) issued an unqualified limited review report with no qualifications or emphasis of matter.
Sharply higher PBT signals robust earnings growth, which is positive for shareholders, though the big drop in cash balance (from ₹5,648 to ₹1,878 lakhs) reflects higher capex and dividend payouts rather than weakness. Low debt and clean audit reinforce financial stability; the stock may react positively to the strong earnings growth.